Chronic Rhinosinusitis Trial, Not Yet Recruiting NCT06669130 Sponsor: The First Affiliated Hospital with Nanjing Medical University Condition: Chronic Rhinosinusitis
Back to Chronic Rhinosinusitis

Chronic Rhinosinusitis Trial, Not Yet Recruiting

NCT06669130
Not Yet Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old, and are either male or a female who is not pregnant
  • You understand the purpose and steps of the trial and are willing to sign a consent form agreeing to take part
  • You have been diagnosed with chronic rhinosinusitis (long-term sinus inflammation) on both sides, confirmed by a CT scan taken within the last 3 months showing a specific level of severity
  • If you are female, you are not currently breastfeeding and do not plan to breastfeed or become pregnant for up to one year after joining the trial
  • You have not taken part in another clinical trial in the past 3 months and agree not to join another trial until this one is finished

Who may not be able to join:

  • You have a known allergy or sensitivity to the materials used in the device or its breakdown products (confirm with trial site)
  • You take long-term oral hormone medications (such as steroids taken by mouth)
  • You are currently receiving treatment that suppresses your immune system, or you have a known immune-related or autoimmune condition
  • You have diabetes
  • You have or have previously had glaucoma or raised pressure in your eyes
  • You have cataracts (clouding of the lens in your eye)
  • You have an artificial eye
  • You currently have an acute (sudden or short-term) bacterial or fungal sinus infection
  • Your doctors expect your life expectancy to be less than 12 months
  • You have previously taken part in a clinical trial where the main goals were not met, or you are unwilling or unable to fully participate in this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13776620807

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
1 October 2025

Primary endpoints

Postoperative reintervention rates based on imaging evaluations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov